|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.292
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.256
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.233
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.203
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.179
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.172
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.161
|
|
|
|
one carbon metabolic process
|
GO:0006730 |
1 |
0.161
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.151
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.148
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.143
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.140
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.139
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.134
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.131
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.127
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.125
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.124
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.122
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.122
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.114
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.105
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.105
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.105
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.098
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.097
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.096
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.096
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.095
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.093
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.093
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.092
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.090
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.088
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.087
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.086
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.084
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.084
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.083
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.080
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.078
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.077
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.075
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.075
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.074
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.072
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.071
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.071
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.070
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.070
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.067
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.066
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.066
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.065
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.065
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.065
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.064
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.064
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.063
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.062
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.062
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.062
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.061
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.061
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.061
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.060
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.060
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.058
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.057
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.057
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.056
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.056
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.056
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.056
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.055
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.055
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.055
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.054
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.053
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.053
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.052
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.052
|
|
|
|
hormone biosynthetic process
|
GO:0042446 |
16 |
0.052
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.051
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.051
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.051
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.051
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.050
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.050
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.049
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.049
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.049
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.048
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.048
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.048
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.047
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.046
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.045
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.044
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.044
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.044
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.044
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.044
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.043
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.043
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.043
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.043
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.043
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.041
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.040
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.040
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.040
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.040
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.040
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.040
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.040
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.040
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.040
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.040
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.039
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.039
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.039
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.039
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.038
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.038
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.038
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.038
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.038
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.038
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.037
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.037
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.037
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.037
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.036
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.036
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.036
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.036
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.036
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.036
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.036
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.036
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.036
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.036
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.036
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.036
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.035
|
|
|
|
regulation of interleukin 1 alpha production
|
GO:0032650 |
4 |
0.035
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.035
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.035
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.035
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.035
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.034
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.034
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.034
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.034
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.034
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.034
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.034
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.033
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.033
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.033
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.033
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.033
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.033
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.033
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.032
|
|
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.032
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.032
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.032
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.032
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.032
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.032
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.032
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.032
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.032
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.032
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.031
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.031
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.031
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.031
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.031
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.031
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.031
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.031
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.031
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.031
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.031
|
|
|
|
positive regulation of syncytium formation by plasma membrane fusion
|
GO:0060143 |
17 |
0.030
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.030
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.030
|
|
|
|
hematopoietic stem cell proliferation
|
GO:0071425 |
13 |
0.030
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.030
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.030
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.030
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.030
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.029
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.029
|
|
|
|
regulation of glycogen catabolic process
|
GO:0005981 |
2 |
0.029
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.029
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.029
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.029
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.029
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.029
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.029
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.029
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.028
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.028
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.028
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.028
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.028
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.028
|
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.028
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.028
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.028
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.028
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.028
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.028
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.028
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.028
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.028
|
|
|
|
folic acid containing compound metabolic process
|
GO:0006760 |
3 |
0.028
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.027
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.027
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.027
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.027
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.027
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.027
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.027
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.027
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.026
|
|
|
|
sensory perception of taste
|
GO:0050909 |
18 |
0.026
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.026
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.026
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.026
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.026
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.026
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.026
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.026
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.026
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.026
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.026
|
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.026
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.026
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.026
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.026
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.026
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.026
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.026
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.026
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.026
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.026
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.026
|
|
|
|
positive regulation of t cell mediated cytotoxicity
|
GO:0001916 |
15 |
0.025
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.025
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.025
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.025
|
|
|
|
regulation of glutamate metabolic process
|
GO:2000211 |
1 |
0.025
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.025
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.025
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.025
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.025
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.025
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.025
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.025
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.025
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.025
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.025
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.025
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.025
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.024
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.024
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.024
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.024
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.024
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.024
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.024
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.024
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.024
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.024
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.024
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.024
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.024
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.024
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.024
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.024
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.024
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.024
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.024
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.023
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.023
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.023
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.023
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.023
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.023
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.023
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.023
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.023
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.023
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.023
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.023
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.023
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.023
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.023
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.023
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.023
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.023
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.023
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.023
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.023
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.022
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.022
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.022
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.022
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.022
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.022
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.022
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.022
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.022
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.022
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.022
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.022
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.022
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.022
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.022
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.022
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.022
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.021
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.021
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.021
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.021
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.021
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.021
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.021
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.021
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.021
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.021
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.021
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.021
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.021
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.021
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.021
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.021
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.021
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.020
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.020
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.020
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.020
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.020
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.020
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.020
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.020
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.020
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.020
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.020
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.020
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.020
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.020
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.020
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.020
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.020
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.020
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.020
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.020
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.020
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.019
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.019
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.019
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.019
|
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.019
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.019
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.019
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.019
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.019
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.019
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.019
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.019
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.019
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.019
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.019
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.019
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.019
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.019
|
|
|
|
regulation of vascular smooth muscle contraction
|
GO:0003056 |
1 |
0.019
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.019
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.019
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.019
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.019
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.019
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.019
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.019
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.019
|
|
|
|
transepithelial chloride transport
|
GO:0030321 |
4 |
0.019
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.019
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.019
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.019
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.018
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.018
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.018
|
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.018
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.018
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.018
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.018
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.018
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.018
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.018
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.018
|
|
|
|
regulation of hormone metabolic process
|
GO:0032350 |
15 |
0.018
|
|
|
|
positive regulation of mammary gland involution
|
GO:1903521 |
4 |
0.018
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.018
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.018
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.018
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.018
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.018
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.018
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.018
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.018
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.018
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.018
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.018
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.018
|
|
|
|
chloride transport
|
GO:0006821 |
32 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.018
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.018
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.017
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.017
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.017
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.017
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.017
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.017
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.017
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.017
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.017
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.017
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.017
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.017
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.017
|
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.017
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.017
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.017
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.017
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.017
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.017
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.017
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.017
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.017
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.016
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.016
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.016
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.016
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.016
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.016
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.016
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.016
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.016
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.016
|
|
|
|
translation
|
GO:0006412 |
93 |
0.016
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.016
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.016
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.016
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.016
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.016
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.016
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.016
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.016
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.016
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.016
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.016
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.016
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.016
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.016
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.016
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.016
|
|
|
|
regulation of t cell mediated immunity
|
GO:0002709 |
34 |
0.016
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.016
|
|
|
|
regulation of t cell mediated cytotoxicity
|
GO:0001914 |
18 |
0.016
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.016
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.016
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.015
|
|
